Financhill
Sell
32

NUWE Quote, Financials, Valuation and Earnings

Last price:
$2.54
Seasonality move :
-4.51%
Day range:
$2.40 - $2.65
52-week range:
$2.02 - $70.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.71x
P/B ratio:
4.68x
Volume:
98.2K
Avg. volume:
96.7K
1-year change:
-95.15%
Market cap:
$18.3M
Revenue:
$8.7M
EPS (TTM):
-$79.42

Analysts' Opinion

  • Consensus Rating
    Nuwellis, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.00, Nuwellis, Inc. has an estimated upside of 17466.56% from its current price of $2.63.
  • Price Target Downside
    According to analysts, the lowest downside price target is $13.00 representing 100% downside risk from its current price of $2.63.

Fair Value

  • According to the consensus of 1 analyst, Nuwellis, Inc. has 17466.56% upside to fair value with a price target of $13.00 per share.

NUWE vs. S&P 500

  • Over the past 5 trading days, Nuwellis, Inc. has overperformed the S&P 500 by 9% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Nuwellis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Nuwellis, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Nuwellis, Inc. reported revenues of $2.2M.

Earnings Growth

  • Nuwellis, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Nuwellis, Inc. reported earnings per share of $0.56.
Enterprise value:
15.6M
EV / Invested capital:
3.63x
Price / LTM sales:
0.71x
EV / EBIT:
--
EV / Revenue:
1.91x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.66x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$4.8M
Return On Assets:
-203.12%
Net Income Margin (TTM):
-202.83%
Return On Equity:
-1004.06%
Return On Invested Capital:
-773.58%
Operating Margin:
-121.65%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $8.7M $9M $8.2M $2.4M $2.2M
Gross Profit $4.9M $5.7M $4.8M $1.7M $1.4M
Operating Income -$18.6M -$12.2M -$11.1M -$1.5M -$2.7M
EBITDA -$18.2M -$11.9M -$10.8M -$1.5M -$2.7M
Diluted EPS -$567.64 -$116.60 -$79.42 $1.74 $0.56
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $32.7M $16.4M $9.6M $5.5M $7.2M
Total Assets $34.1M $18.4M $11.4M $6.7M $8M
Current Liabilities $3.8M $3.6M $3M $2.7M $3.5M
Total Liabilities $4.1M $4.4M $3.6M $3.5M $4.1M
Total Equity $30M $14M $7.8M $3.2M $3.9M
Total Debt $168K $845K $609K $368K $128K
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$18.3M -$10.8M -$9.3M -$2.5M -$3.1M
Cash From Investing $15.1M -$1K -$125K $16K -$98K
Cash From Financing $11.5M $7.8M $10.6M $3.3M $1.9M
Free Cash Flow -$18.6M -$10.8M -$9.4M -$2.5M -$3.2M
NUWE
Sector
Market Cap
$18.3M
$28.8M
Price % of 52-Week High
3.75%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
-45.28%
-1.32%
1-Year Price Total Return
-95.15%
-20.64%
Beta (5-Year)
-0.165
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $2.35
200-day SMA
Sell
Level $19.57
Bollinger Bands (100)
Sell
Level 1.66 - 8.26
Chaikin Money Flow
Sell
Level -34.5M
20-day SMA
Buy
Level $2.45
Relative Strength Index (RSI14)
Buy
Level 50.10
ADX Line
Buy
Level 9.75
Williams %R
Sell
Level -10.9489
50-day SMA
Sell
Level $2.98
MACD (12, 26)
Sell
Level -0.20
25-day Aroon Oscillator
Sell
Level -68
On Balance Volume
Neutral
Level 44.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-7.7344)
Sell
CA Score (Annual)
Level (-5.179)
Buy
Beneish M-Score (Annual)
Level (-210.007)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.7477)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Stock Forecast FAQ

In the current month, NUWE has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NUWE average analyst price target in the past 3 months is $13.00.

  • Where Will Nuwellis, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Nuwellis, Inc. share price will rise to $13.00 per share over the next 12 months.

  • What Do Analysts Say About Nuwellis, Inc.?

    Analysts are divided on their view about Nuwellis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nuwellis, Inc. is a Sell and believe this share price will drop from its current level to $13.00.

  • What Is Nuwellis, Inc.'s Price Target?

    The price target for Nuwellis, Inc. over the next 1-year time period is forecast to be $13.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is NUWE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Nuwellis, Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of NUWE?

    You can purchase shares of Nuwellis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nuwellis, Inc. shares.

  • What Is The Nuwellis, Inc. Share Price Today?

    Nuwellis, Inc. was last trading at $2.54 per share. This represents the most recent stock quote for Nuwellis, Inc.. Yesterday, Nuwellis, Inc. closed at $2.63 per share.

  • How To Buy Nuwellis, Inc. Stock Online?

    In order to purchase Nuwellis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 105.84% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 1.85% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is down 0.66% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock